Abstract
Hemizygous and homozygous deletions of chromosomal band 9p21 have been detected in various tumor types as well as in more than 20% of acute lymphoblastic leukemia. Recently, the CDKN2 gene (pl6INK4A, MTS I, CDK4I) has been proposed as a candidate tumor suppressor gene because it is frequently deleted in cell lines derived from multiple tumor types. We examined 18 leukemia-derived cell lines (13 T-ALL, 3 B-cell-precursor ALL,1 AML,1 CML-blast crisis) by polymerase chain reaction and Southern blot analysis to further define the frequency and size of 9p deletions in hematological malignancies. Homozygous CDKN2 deletions were detected in 16 cell lines (89%). Interphase fluorescence in situ hybridization (FISH) is a powerful method to detect chromosomal rearrangements, including submicroscopic deletions. Using a cosmid contig of the CDKN2 region, we performed interphase FISH in nine cell lines to study the accuracy of this method in detecting 9p deletions. Interphase FISH determined accurately all deletions of the tumor suppressor region previously detected by Southern blot or PCR. In six cell lines the cosmid contig was completely deleted. In one cell line, the intensity of the hybridization signals was significantly reduced, indicating a partial deletion of the hybridization region. One cell line had a hemizygous deletion which is difficult to detect by molecular techniques. Genomic deletions seem to be the predominant mechanism of CDKN2 inactivation in acute leukemias. Interphase FISH will play an important role in defining the frequency of CDKN2 deletions in primary tumors, because it is able reliably to analyze clinical samples that are contaminated by normal cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chilcote, R.R., Brown, E., and Rowley, J.D. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med, 313: 286–291, 1985.
Murphy, S.B., Raimondi, S.C., Rivera, G.K., Crone, M., Dodge, R.K., Behm. F.G., Pui, C.H., and Williams, D.L. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia. Blood, 74: 409–415, 1989.
Kamb, A., Gruis, N.A., Weaver, F.J., Liu, Q., Harshman, K., Tavtigian, S.V., Strockert, Day III, R., Johnson, B.E., and Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264: 436–40, 1994.
Diaz, M.O., Ziemin, S., Le Beau, M.M., Pitha, P., Smith, S.D., Chilcote,.R.R., and Rowley, J.D. Homozygous deletion of the α- and β-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA, 85: 5259–5263, 1988.
Diaz, M.O., Rubin, C.M., Harden, A., Ziemin, S., Larson, R.A., LeBeau, M.M., and Rowley, J.D. Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med, 322: 77–82, 1990.
James, C.D., J., C., Caarlbom, E., Nordenskjold, M., Cavenee, W.K., and Collins, V.P. Chromosome 9 deletion mapping reveals interferon A and interferon B gene deletions in human glial tumors. Cancer Res, 51: 1684–1688, 1991.
Olopade, O.I., Jenkins, R.B., Ransom, D.T., Malik, K., Pomykala, H., Nobori, T., Cowan, J.M., Rowley, J.D., and Diaz, M.O. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res, 52: 2523–2529, 1992.
Olopade, O.I., Buchhagen, D.L., Malik, K., Sherman, J., Nobori, T., Bader, S., Nau, M.M., Gazdar, A.F., Minna, J.D., and Diaz, M.O., Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res, 53: 2410–2415, 1993.
Serrano, M., Hannon, G.J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366: 704–707, 1993.
Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K., and Carson, D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368: 753–756, 1994.
Hannon, G.J. and Beach, D. pl5INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371: 257–261, 1994.
James, C.D., Carlboom, E., Dumanski, J.D., Hansen, M., Nordenskjold, M., Collins, V.P., and Cavenee, W.K. Clonal genomic alterations in glioma malignancy stages. Cancer Res, 48: 5546–5551, 1988.
Feinberg, A.P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem, 132: 6–13, 1983.
Bohlander, S.K., Dreyling, M.H., Hagos, F., Sveen, L., Olopade, O.I., and Diaz, M.O. Mapping of a putative tumor suppressor gene on chromosome 9 band p21-22 with microdissection probes. Genomics, 24: 211–217, 1994.
Olopade, O.I., Pomykala, H.M., Hagos, F., Sveen, L.W., Espinosa III, R., Dreyling, M.H., Gursky, S., Stadler, W.M., Le Beau, M.M., and Bohlander, S.K. Construction of a 2.8 megabase YAC contig and cloning of the methyladenosine phosphorylase (MTAP) gene from the tumor suppressor region on 9p2. Proc Natl Acad Sci USA, in press.
Schneider, C., Owen, M.J., Banville, D., and Williams, J.G. Primary structure of the human transferrin receptor deduced from the mRNA sequence. Nature, 311: 675–678, 1984.
Henco, K., Brosius, J., Fujisawa, J.I., Haynes, J.R., Hochstadt, J., Kovacic, T., Pasek, M., Schambock, A., Schmid, S., Todokoro, K., Walchli, M., Nagata, S., and Weissmann, C. Structural relationship of human interferon alpha genes and pseudogenes. J Med Biol, 185: 227–260, 1988.
Le Beau, M.M. Cytogenetic analysis of hematological malignant diseases. In: M.J. Barch, The ACT cytogenetics laboratory manual, pp.395–445. New York: Raven Press, 1994.
Dreyling, M., Olopade, O.I., and Bohlander, S.K. A method for screening arrayed cosmid libraries with mega insert yeast artificial chromosomes. Nucl Acids Res, in press.
Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J.D., and Drabkin, H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript AML1/ETO, with similarity to drosophila segmentation gene, runt. Blood, 80: 1825–831, 1992.
Moyzis, R.K., Albright, K.L., Bartholdi, M.F., Cram, L.S., Deaven, L.L., Hildebrand, C.E., Joste, N.E., Longmire, J.L., Meyne, J., and Schwarzacher-Robinson, T. Human chromosome-specific repetitive DNA sequences: Novel marker for genetic analysis Chromosoma, 95: 375–386, 1987.
Bohlander, S.K., Espinosa III, R., Fernald, A.A., Rowley, J.D., Le Beau, M.M., and Diaz, M.O. Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet Cell Genet, 65: 108–110, 1994.
Rowley, J.D., Diaz, M.O., Espinosa III, R., Patel, Y.D., van Melle, E., Ziemin, S., Taillon-Miller, P., Lichter, P., Evans, G.A., Kersey, J.H., Ward, D.C. Domer, P.H., and Le Beau, M.M. Mapping chromosome band 11q23 im human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87: 9358–9362, 1990.
Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., Yazaki, Y., and Hirai, H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (pi6) gene in human leukemias. Blood, 84: 2431–2435, 1994.
Nakamaki, T., Tobler, A., Schwaller, J., Tsuruoka, N., Miller, C.W., and Koeffler, H.P. pl6-alterations in myeloid leukemias. Blood, 84(Suppl 1): 48a, 1994 (abstract).
Gombart, A.F., Shintaku, I.P., Said, J.W., Miller, C.W., and Koeffler, H.P. Alterations of the CDK4/MTS1 (cyclin-dependent kinase 4 inhibitor/ multiple tumor suppressor 1) gene in uncultured B-cell lymphoma. Blood, 84 (Suppl 1): 445a, 1994(abstract).
Cairns, P., Mao, L., Merlo, A., Lee, D.J., Schwab, D., Ebry, Y., Tokino, K., van der Riet, P., Blaugrund, J.E., and Sidransky, D. Rates of pl6 (MTSl) mutations in primary tumors with 9p loss. Science, 265: 415–416, 1994(letter).
Giani, C. and Finocchiaro, G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res, 54: 6338–6339, 1994.
Jen, J., Harper, J.W., Bigner, S.H., Bigner, D.D., Papadopoulos, N., Markowitz, S., Willson, J.K.V., Kinzler, K.W., and Vogelstein, B. Deletion of pl6 and p15 genes in brain tumors. Cancer Res, 54: 6353–6358, 1994.
Okamoto, A., Demetrick, D.J., Spillare, E.A., Hagiwara, K., Hussain, S.P., Bennett, W.P., Forrester, K., Gerwin, B., Serrano, M., Beach, D.H., and Harris, C.C. Mutations and altered expression of pl6INK4 in human cancer. Proc Natl Acad Sci USA, 91: 11045–11049, 1994.
Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J.L., Bauters, F., Wattel, E., and Fenaux, P. pl6 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85: 657–663, 1995.
Stilgenbauer, S., Dohner, H., Bulgay-Morschel, M., Weitz, S., Bentz, M., and Lichter, P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood, 81: 2118–2124, 1993.
Bohlander, S.K., Espinosa III, R., Le Beau, M.M., Rowley, J.D., and Diaz, M.O. A method for the rapid sequence-independent amplification of microdissected chromosomal material. Genomics, 13: 1322–1324, 1992.
Nelson, D.L., Ledbetter, S.A., Corbo, L., Victoria, M.F., Ramirez-Solis, R., Webster, T.D., Ledbetter, D.H., and Caskey, C.T. Alu polymerase chain reaction: A method for rapid isolation of humanspecific sequences from complex DNA sources. Proc Natl Acad Sci USA, 86: 6686–6690, 1989.
Tocharentanaphol, C., Cremer, M., Schröck, E., Blonden, L., Kilian, K., Cremer, T., and Ried, T. Multicolor fluorescence in situ hybridization on metaphase chromosomes and interphase Halopreparations using cosmid and YAC clones for the simultaneous high resolution mapping of deletions in the dystrophin gene. Hum Genet, 93: 229–235, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dreyling, M.H., Olopade, O.I., Bohlander, S.K. (1997). CDKN2 Deletions in Leukemia-Derived Cell Lines: Detection by Fluorescence In Situ Hybridization with Interphase Cells. In: Büchner, T., Schellong, G., Ritter, J., Creutzig, U., Hiddemann, W., Wörmann, B. (eds) Acute Leukemias VI. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60377-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-60377-8_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64379-8
Online ISBN: 978-3-642-60377-8
eBook Packages: Springer Book Archive